Cover Image
市場調查報告書

醫藥品賦形劑的全球市場預測 2023年:填充劑、塗料劑、粘合劑、崩壞劑、著色劑、防腐劑、乳化劑

Pharmaceutical Excipients Market by Type (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical), Functionality (Filler, Coating, Disintegrant, Binder), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 289198
出版日期 內容資訊 英文 275 Pages
訂單完成後即時交付
價格
Back to Top
醫藥品賦形劑的全球市場預測 2023年:填充劑、塗料劑、粘合劑、崩壞劑、著色劑、防腐劑、乳化劑 Pharmaceutical Excipients Market by Type (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical), Functionality (Filler, Coating, Disintegrant, Binder), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2023
出版日期: 2018年03月22日 內容資訊: 英文 275 Pages
簡介

全球醫藥品賦形劑市場,預計從2018年到2023年,以5.9%的年複合成長率擴大。該市場規模預計從2018年的64億美元到2023年達到85億3,000萬美元。整體醫藥品賦形劑市場的成長,由功能性賦形劑的進步伴隨的醫藥品市場成長,學名藥市場擴大,生物帶動醫藥品市場的成長等要素大幅促進。可是,法規的嚴格化擴大,花費成本、時間的藥物研發流程,對賦形劑製造商品質的擔憂,對該市場的成長構成大課題。

本報告提供全球醫藥品賦形劑市場相關調查分析,市場概要,各產品、功能、賦形、主要國家/地區的分析與預測,競爭情形,及主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 醫藥品賦形劑:市場概要
  • 醫藥品賦形劑市場:地區的成長機會
  • 地區結構:醫藥品賦形劑市場
  • 亞太地區的醫藥品賦形劑市場:各類型
  • 醫藥品賦形劑市場:新興市場 vs. 已發展的市場

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進成長要素
    • 阻礙成長要素
    • 機會
    • 課題

第6章 產業考察

  • 簡介
  • 產業趨勢
  • 法規分析

第7章 醫藥品賦形劑市場:各產品

  • 簡介
  • 有機化學藥品
    • 油脂化學藥品
    • 碳水化合物
    • 石油化學藥品
    • 蛋白質
    • 其他
  • 無機化學藥品
    • 磷酸鈣
    • 金屬氧化物
    • 岩鹽
    • 碳酸鈣
    • 硫酸鈣
    • 其他
  • 其他的化學藥品

第8章 醫藥品賦形劑市場:各功能

  • 簡介
  • 填充劑及稀釋劑
  • 懸浮液 & 粘性劑
  • 塗料劑
  • 粘合劑
  • 香料添加劑 & 甜味劑
  • 崩壞劑
  • 著色劑
  • 潤滑油及流動催化劑
  • 防腐劑
  • 乳化劑
  • 其他功能性劑

第9章 醫藥品賦形劑市場:各劑型

  • 簡介
  • 口服賦形劑
    • 藥丸
    • 膠囊劑
    • 液劑
  • 局部賦形劑
  • 非口服製劑
  • 最新的通知系統

第10章 醫藥品賦形劑市場:各地區

  • 簡介
  • 歐洲
    • 瑞士
    • 德國
    • 義大利
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 其他
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形與趨勢

第12章 企業簡介

  • DOWDUPONT
  • ROQUETTE
  • ASHLAND
  • BASF
  • KERRY
  • EVONIK INDUSTRIES
  • CRODA
  • ASSOCIATED BRITISH FOODS
  • ARCHER DANIELS MIDLAND
  • LUBRIZOL
  • INNOPHOS HOLDINGS
  • WACKER CHEMIE
  • SIGNET

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PH 3047

"The pharmaceutical excipients market is projected to grow at a CAGR of 5.9% between 2018 and 2023."

The pharmaceutical excipients market is expected to reach USD 8.53 billion by 2023 from USD 6.40 billion in 2018, at a CAGR of 5.9%. The overall growth of the pharmaceutical excipients market is largely driven by the growing pharmaceutical market along with the advancements in functional excipients, growing generics market, rapidly growing biopharmaceuticals sector, emergence of multifunctional & co-processed excipients, shifting focus of pharmaceutical manufacturing to emerging markets, and the growing biosimilar industry. However, the increasing regulatory stringency, cost and time-intensive drug development process, and the quality concerns of excipient manufacturers represent a significant challenge to the market growth.

"The lubricants and glidants segment is expected to grow at the fastest rate during the forecast period."

On the basis of functionality, the pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The lubricants & glidants segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the rising uptake of these excipients to reduce clumping of ingredients and friction between a tablet and the dye cavity along with increasing flowability.

"APAC to witness the highest growth during the forecast period"

Geographically, the pharmaceutical excipients market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, Europe commanded a major share of the pharmaceutical excipients market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the low labor and manufacturing costs in China and India, cost-effective outsource manufacturing processes, increasing generic drug manufacturers, and less stringent regulations.

Breakup of Primary Participants:

  • By Company Type - Tier 1: 45%, Tier 2-33%, and Tier 3-22%
  • By Designation - C Level: 43%, Director Level: 38%, and Others: 19%
  • By Region - North America: 41%, Europe: 30%, Asia Pacific: 23%, and Rest of the World: 6%

The players competing in this market are: DowDuPont (US), Ashland (US), BASF (Germany), Roquette (France), Evonik (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), Croda (UK), Innophous Holdings (US), Kerry Group (Ireland), WACKER CHEMIE (Germany), and Signet (India).

Research Coverage:

The report analyzes the various types of pharmaceutical excipients in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the pharmaceutical excipients market for different segments such as product, functionality, type of formulations, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies for strengthening their market position.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pharmaceutical excipients market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the pharmaceutical excipients market
  • Market Development: Comprehensive information about lucrative emerging markets by product, functionality, type of formulations, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the pharmaceutical excipients market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the pharmaceutical excipients market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Break down of primaries
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION APPROACH
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PHARMACEUTICAL EXCIPIENTS: MARKET OVERVIEW
  • 4.2 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.3 REGIONAL MIX: PHARMACEUTICAL EXCIPIENTS MARKET (2018-2023)
  • 4.4 ASIA PACIFIC: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE (2017)
  • 4.5 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Growth of the pharmaceuticals market backed by functional excipients
      • 5.2.1.2 Surge in the generics market
      • 5.2.1.3 Increasing uptake of biopharmaceuticals
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Cost and time-intensive drug development process
      • 5.2.2.2 Increasing regulatory stringency
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Multifunctionality excipients are proving to be emerging areas of new product development
      • 5.2.3.2 Shifting focus of pharmaceutical manufacturing to emerging countries
      • 5.2.3.3 Growth in the biosimilars market
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Safety and quality concerns

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 RISING DEMAND AND EMPHASIS ON CO-PROCESSED EXCIPIENTS
    • 6.2.2 IMPROVING EXCIPIENT CAPABILITIES BY USING NANOTECHNOLOGY
    • 6.2.3 INCREASING USE OF DIRECT COMPRESSION IN ORAL DOSAGE FORMULATIONS
  • 6.3 REGULATORY ANALYSIS
    • 6.3.1 NORTH AMERICA
      • 6.3.1.1 US
      • 6.3.1.2 Canada
    • 6.3.2 EUROPE
    • 6.3.3 ASIA PACIFIC
      • 6.3.3.1 Japan
      • 6.3.3.2 China
      • 6.3.3.3 India

7 PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 ORGANIC CHEMICALS
    • 7.2.1 OLEOCHEMICALS
      • 7.2.1.1 Fatty alcohols
      • 7.2.1.2 Mineral stearates
      • 7.2.1.3 Glycerin
      • 7.2.1.4 Other oleochemical excipients
    • 7.2.2 CARBOHYDRATES
      • 7.2.2.1 Sugars
        • 7.2.2.1.1 Actual Sugars
        • 7.2.2.1.1.1 Lactose
        • 7.2.2.1.1.2 Sucrose
        • 7.2.2.1.1.3 Dextrose (D-Glucose)
        • 7.2.2.1.2 Sugar alcohols
        • 7.2.2.1.2.1 Sorbitol
        • 7.2.2.1.2.2 Mannitol
        • 7.2.2.1.2.3 Other Sugar Alcohols
        • 7.2.2.1.3 Artificial Sweeteners
      • 7.2.2.2 Cellulose
        • 7.2.2.2.1 Microcrystalline Cellulose
        • 7.2.2.2.2 Cellulose Ethers
        • 7.2.2.2.3 CMC and croscarmellose sodium
        • 7.2.2.2.4 Cellulose esters
      • 7.2.2.3 Starch
        • 7.2.2.3.1 Modified starch
        • 7.2.2.3.2 Dried starch
        • 7.2.2.3.3 Converted starch
    • 7.2.3 PETROCHEMICALS
      • 7.2.3.1 Glycols
        • 7.2.3.1.1 Polyethylene glycol
        • 7.2.3.1.2 Propylene glycol
      • 7.2.3.2 Povidones
      • 7.2.3.3 Mineral hydrocarbons
        • 7.2.3.3.1 Petrolatum
        • 7.2.3.3.2 Mineral waxes
        • 7.2.3.3.3 Mineral oils
      • 7.2.3.4 Acrylic polymers
      • 7.2.3.5 Other petrochemical excipients
    • 7.2.4 PROTEINS
    • 7.2.5 OTHER ORGANIC CHEMICALS
  • 7.3 INORGANIC CHEMICALS
    • 7.3.1 CALCIUM PHOSPHATES
    • 7.3.2 METAL OXIDES
    • 7.3.3 HALITES
    • 7.3.4 CALCIUM CARBONATES
    • 7.3.5 CALCIUM SULFATES
    • 7.3.6 OTHER INORGANIC CHEMICALS
  • 7.4 OTHER CHEMICALS

8 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

  • 8.1 INTRODUCTION
  • 8.2 FILLERS & DILUENTS
  • 8.3 SUSPENDING & VISCOSITY AGENTS
  • 8.4 COATING AGENTS
  • 8.5 BINDERS
  • 8.6 FLAVORING AGENTS & SWEETENERS
  • 8.7 DISINTEGRANTS
  • 8.8 COLORANTS
  • 8.9 LUBRICANTS & GLIDANTS
  • 8.10 PRESERVATIVES
  • 8.11 EMULSIFYING AGENTS
  • 8.12 OTHER FUNCTIONALITIES

9 PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION

  • 9.1 INTRODUCTION
  • 9.2 ORAL FORMULATIONS
    • 9.2.1 TABLETS
    • 9.2.2 CAPSULES
      • 9.2.2.1 Hard gelatin capsules
      • 9.2.2.2 Soft gelatin capsules
    • 9.2.3 LIQUID FORMULATIONS
  • 9.3 TOPICAL FORMULATIONS
  • 9.4 PARENTERAL FORMULATIONS
  • 9.5 OTHER FORMULATIONS

10 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 EUROPE
    • 10.2.1 SWITZERLAND
    • 10.2.2 GERMANY
    • 10.2.3 ITALY
    • 10.2.4 FRANCE
    • 10.2.5 UK
    • 10.2.6 SPAIN
    • 10.2.7 REST OF EUROPE
  • 10.3 NORTH AMERICA
    • 10.3.1 US
    • 10.3.2 CANADA
  • 10.4 ASIA PACIFIC
    • 10.4.1 JAPAN
    • 10.4.2 CHINA
    • 10.4.3 INDIA
    • 10.4.4 SOUTH KOREA
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
  • 10.6 MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS
    • 11.2.1 MARKET SHARE ANALYSIS: GLOBAL
    • 11.2.2 MARKET SHARE ANALYSIS: NORTH AMERICA
    • 11.2.3 MARKET SHARE ANALYSIS: EUROPE
    • 11.2.4 MARKET SHARE ANALYSIS: ASIA PACIFIC
  • 11.3 COMPETITIVE SITUATION AND TRENDS
    • 11.3.1 EXPANSIONS
    • 11.3.2 ACQUISITIONS
    • 11.3.3 PRODUCT LAUNCHES
    • 11.3.4 OTHER STRATEGIES

12 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1 DOWDUPONT
  • 12.2 ROQUETTE
  • 12.3 ASHLAND
  • 12.4 BASF
  • 12.5 KERRY
  • 12.6 EVONIK INDUSTRIES
  • 12.7 CRODA
  • 12.8 ASSOCIATED BRITISH FOODS
  • 12.9 ARCHER DANIELS MIDLAND
  • 12.10 LUBRIZOL
  • 12.11 INNOPHOS HOLDINGS
  • 12.12 WACKER CHEMIE
  • 12.13 SIGNET

Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: DRUGS COMING OFF-PATENT
  • TABLE 2: KEY MARKET DRIVERS: IMPACT ANALYSIS
  • TABLE 3: KEY MARKET RESTRAINTS: IMPACT ANALYSIS
  • TABLE 4: MULTIFUNCTIONAL EXCIPIENTS
  • TABLE 5: CLINICAL STUDIES FOR BIOLOGICS & BIOSIMILARS (2017)
  • TABLE 6: KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
  • TABLE 7: KEY MARKET CHALLENGES: IMPACT ANALYSIS
  • TABLE 8: MARKETED CO-PROCESSED EXCIPIENTS
  • TABLE 9: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 10: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 11: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 12: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 13: OLEOCHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 14: OLEOCHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 15: FATTY ALCOHOL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 16: MINERAL STEARATE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 17: GLYCERIN EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 18: OTHER OLEOCHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 19: CARBOHYDRATE EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 20: CARBOHYDRATE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 21: SUGAR EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 22: SUGAR EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 23: ACTUAL SUGAR EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 24: ACTUAL SUGAR EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 25: SUGAR ALCOHOL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 26: SUGAR ALCOHOL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 27: ARTIFICIAL SWEETENER EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 28: CELLULOSE EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: CELLULOSE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 30: MICROCRYSTALLINE CELLULOSE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 31: CELLULOSE ETHER EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 32: CMC & CROSCARMELLOSE SODIUM EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 33: CELLULOSE ESTER EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 34: STARCH EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 35: STARCH EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 36: MODIFIED STARCH EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 37: DRIED STARCH EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 38: CONVERTED STARCH EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 39: PETROCHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 40: PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 41: GLYCOL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 42: GLYCOL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 43: POVIDONE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 44: MINERAL HYDROCARBON EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 45: MINERAL HYDROCARBON EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 46: ACRYLIC POLYMER EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 47: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 48: PROTEIN EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 49: OTHER ORGANIC CHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 50: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 51: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 52: CALCIUM PHOSPHATE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 53: METAL OXIDE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 54: HALITE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 55: CALCIUM CARBONATE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 56: CALCIUM SULFATE EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 57: OTHER INORGANIC CHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 58: OTHER CHEMICAL EXCIPIENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 59: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 60: PHARMACEUTICAL FILLERS & DILUENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 61: PHARMACEUTICAL SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 62: PHARMACEUTICAL COATING AGENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 63: PHARMACEUTICAL BINDERS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 64: PHARMACEUTICAL FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 65: PHARMACEUTICAL DISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 66: PHARMACEUTICAL COLORANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 67: PHARMACEUTICAL LUBRICANTS & GLIDANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 68: PHARMACEUTICAL PRESERVATIVES MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 69: PHARMACEUTICAL EMULSIFYING AGENTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 70: OTHER FUNCTIONALITIES MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 71: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 72: EXCIPIENTS FOR ORAL FORMULATIONS
  • TABLE 73: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 75: TYPICAL COMPOSITION OF TABLETS
  • TABLE 76: PHARMACEUTICAL EXCIPIENTS MARKET FOR TABLET FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 77: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULE FORMULATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: PHARMACEUTICAL EXCIPIENTS MARKET FOR CAPSULE FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 79: PHARMACEUTICAL EXCIPIENTS MARKET FOR HARD GELATIN CAPSULE FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 80: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOFT GELATIN CAPSULE FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 81: PHARMACEUTICAL EXCIPIENTS MARKET FOR LIQUID FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 82: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 83: TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
  • TABLE 84: EXCIPIENTS USED IN PARENTERAL FORMULATIONS
  • TABLE 85: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 86: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 87: PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 88: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 89: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 90: EUROPE: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 94: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 95: SWITZERLAND: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: SWITZERLAND: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 98: SWITZERLAND: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 99: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 100: GERMANY: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: GERMANY: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 103: GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 104: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 105: ITALY: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: ITALY: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 108: ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 109: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 110: FRANCE: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: FRANCE: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 113: FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 114: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 115: UK: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: UK: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 118: UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 119: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 120: SPAIN: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: SPAIN: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 123: SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 124: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 125: ROE: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 126: ROE: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 128: ROE: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 129: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 130: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 131: NORTH AMERICA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: NORTH AMERICA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 133: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 134: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 135: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 136: US: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 137: US: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 139: US: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 140: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 141: CANADA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: CANADA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 144: CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 145: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 146: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 147: ASIA PACIFIC: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: ASIA PACIFIC: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 150: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 151: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 152: JAPAN: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: JAPAN: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 155: JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 156: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 157: CHINA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 158: CHINA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 160: CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 161: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 162: INDIA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: INDIA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 165: INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 166: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 167: SOUTH KOREA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: SOUTH KOREA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 170: SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 171: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 172: ROAPAC: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: ROAPAC: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 174: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 175: ROAPAC: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 176: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 177: LATIN AMERICA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 178: LATIN AMERICA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 180: LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 181: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 182: MIDDLE EAST AND AFRICA: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: MIDDLE EAST AND AFRICA: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2016-2023 (USD MILLION)
  • TABLE 185: MIDDLE EAST AND AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 186: GROWTH STRATEGY MATRIX (2014-2017)
  • TABLE 187: EXPANSIONS, 2014-2017
  • TABLE 188: ACQUISITIONS, 2014-2017
  • TABLE 189: PRODUCT LAUNCHES, 2014-2017
  • TABLE 190: OTHER STRATEGIES, 2014-2017

LIST OF FIGURES

  • FIGURE 1: GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: ORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: INORGANIC CHEMICAL EXCIPIENTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL EXCIPIENTS MARKET
  • FIGURE 13: GROWING PHARMACEUTICALS INDUSTRY COUPLED WITH ADVANCEMENTS IN FUNCTIONAL EXCIPIENTS-MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 14: ASIA PACIFIC & LATIN AMERICA SHOW HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 16: OLEOCHEMICALS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC ORGANIC CHEMICAL EXCIPIENTS MARKET IN 2017
  • FIGURE 17: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN 2018 & 2023
  • FIGURE 18: PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 19: GLOBAL PHARMACEUTICAL DRUG SALES (2008-2022)
  • FIGURE 20: ESTIMATED PRE-APPROVAL COST OF BRINGING A NEW CHEMICAL OR BIOLOGICAL ENTITY TO MARKET (1970-2010)
  • FIGURE 21: TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) & NEW BIOLOGIC LICENSE APPLICATION (BLA) FILINGS AND APPROVALS IN THE US, 2006-2015
  • FIGURE 22: INCREASING FOCUS ON CO-PROCESSED EXCIPIENTS AND USE OF NANOTECHNOLOGY IN EXCIPIENT PRODUCTION ARE THE LEADING TRENDS IN THE INDUSTRY
  • FIGURE 23: OLEOCHEMICALS ARE EXPECTED TO DOMINATE THE ORGANIC CHEMICAL EXCIPIENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: CALCIUM PHOSPHATES ACCOUNTED FOR THE LARGEST SHARE OF THE INORGANIC CHEMICAL EXCIPIENTS MARKET IN 2017
  • FIGURE 25: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018 VS. 2023
  • FIGURE 26: ORAL FORMULATIONS TO FORM THE LARGEST SEGMENT IN THE PHARMACEUTICAL EXCIPIENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC SNAPSHOT (2017)
  • FIGURE 28: EUROPE PHARMACEUTICAL PRODUCTION, 2015 (USD MILLION)
  • FIGURE 29: EUROPE GENERICS MARKET (2014)
  • FIGURE 30: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • FIGURE 31: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • FIGURE 32: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
  • FIGURE 33: EXPANSIONS-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2014 TO 2017
  • FIGURE 34: GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 35: NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, 2017
  • FIGURE 36: EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, 2017
  • FIGURE 37: ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET SHARE, 2017
  • FIGURE 38: DOWDUPONT: COMPANY SNAPSHOT
  • FIGURE 39: ROQUETTE: COMPANY SNAPSHOT
  • FIGURE 40: ASHLAND: COMPANY SNAPSHOT
  • FIGURE 41: BASF: COMPANY SNAPSHOT
  • FIGURE 42: KERRY: COMPANY SNAPSHOT
  • FIGURE 43: EVONIK INDUSTRIES: COMPANY SNAPSHOT
  • FIGURE 44: CRODA: COMPANY SNAPSHOT
  • FIGURE 45: ASSOCIATED BRITISH FOODS: COMPANY SNAPSHOT
  • FIGURE 46: ARCHER DANIELS MIDLAND: COMPANY SNAPSHOT
  • FIGURE 47: LUBRIZOL: COMPANY SNAPSHOT
  • FIGURE 48: INNOPHOS HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 49: WACKER CHEMIE: COMPANY SNAPSHOT
Back to Top